Literature DB >> 28441545

Targeted mass spectrometry: An emerging powerful approach to unblock the bottleneck in phosphoproteomics.

Nerea Osinalde1, Kerman Aloria2, Miren J Omaetxebarria3, Irina Kratchmarova4.   

Abstract

Following the rapid expansion of the proteomics field, the investigation of post translational modifications (PTM) has become extremely popular changing our perspective of how proteins constantly fine tune cellular functions. Reversible protein phosphorylation plays a pivotal role in virtually all biological processes in the cell and it is one the most characterized PTM up to date. During the last decade, the development of phosphoprotein/phosphopeptide enrichment strategies and mass spectrometry (MS) technology has revolutionized the field of phosphoproteomics discovering thousands of new site-specific phosphorylations and unveiling unprecedented evidence about their modulation under distinct cellular conditions. The field has expanded so rapidly that the use of traditional methods to validate and characterize the biological role of the phosphosites is not feasible any longer. Targeted MS holds great promise for becoming the method of choice to study with high precision and sensitivity already known site-specific phosphorylation events. This review summarizes the contribution of large-scale unbiased MS analyses and highlights the need of targeted MS-based approaches for follow-up investigation. Additionally, the article illustrates the biological relevance of protein phosphorylation by providing examples of disease-related phosphorylation events and emphasizes the benefits of applying targeted MS in clinics for disease diagnosis, prognosis and drug-response evaluation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Keywords:  Disease; Mass spectrometry; Phosphoproteomics; Phosphorylation; Targeted MS

Mesh:

Substances:

Year:  2017        PMID: 28441545     DOI: 10.1016/j.jchromb.2017.04.026

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

Review 1.  Fshb Knockout Mouse Model, Two Decades Later and Into the Future.

Authors:  T Rajendra Kumar
Journal:  Endocrinology       Date:  2018-05-01       Impact factor: 4.736

2.  Novel Antibody-Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma.

Authors:  Lona Zeneyedpour; Christoph Stingl; Johan M Kros; Peter A E Sillevis Smitt; Theo M Luider
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

3.  Evaluating Spatiotemporal Dynamics of Phosphorylation of RNA Polymerase II Carboxy-Terminal Domain by Ultraviolet Photodissociation Mass Spectrometry.

Authors:  Edwin E Escobar; Mukesh Kumar Venkat Ramani; Yan Zhang; Jennifer S Brodbelt
Journal:  J Am Chem Soc       Date:  2021-05-31       Impact factor: 16.383

4.  High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human Tumors.

Authors:  Lauren E Stopfer; Cameron T Flower; Aaron S Gajadhar; Bhavin Patel; Sebastien Gallien; Daniel Lopez-Ferrer; Forest M White
Journal:  Cancer Res       Date:  2021-01-28       Impact factor: 13.312

Review 5.  Monitoring of Plant Protein Post-translational Modifications Using Targeted Proteomics.

Authors:  Borjana Arsova; Michelle Watt; Björn Usadel
Journal:  Front Plant Sci       Date:  2018-08-17       Impact factor: 5.753

Review 6.  Histidine kinases and the missing phosphoproteome from prokaryotes to eukaryotes.

Authors:  Kevin Adam; Tony Hunter
Journal:  Lab Invest       Date:  2017-10-23       Impact factor: 5.662

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.